СУЧАСНИЙ ПОГЛЯД НА ПРОБЛЕМУ БРОНХОЛЕГЕНЕВОЇ ДИСПЛАЗІЇ ТА ВІДКРИТОЇ АРТЕРІАЛЬНОЇ ПРОТОКИ У НЕДОНОШЕНИХ НОВОНАРОДЖЕНИХ

A. Obolonskyy, V. Snysar, O. Obolonskaya

Анотація


У статті відображені сучасні аспекти патогенезу та клініки бронхолегеневої дисплазії у недоношених новонароджених. Надано аналіз впливу різних антенатальних та інтранатальних факторів на формування та перебіг бронхолегеневої дисплазії. Окремо розглянуто проблему відкритої артеріальної протоки, патогенез, механізми впливу на розвиток бронхолегеневої дисплазії та обтяження її стану. Розглянуто клінічні та патогенетичні апекти функціонування відкритої артеріальної протоки у не доношених новонароджених.

Ключові слова


недоношені новонароджені; бронхолегенева дисплазія; відкрита артеріальна протока

Повний текст:

PDF

Посилання


.1 Trembath A, Laughon M. Predictors of Bronchopulmonary Dysplasia. Clin Perinatol. 2013;39(3):585–601.

.2 Laughon MM, Langer JC, Bose CL et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med. 2011;183:1715–22.

.3 Mourani PM, Abman SH. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr. Opin. Pediatr. 2013;25:329–337.

.4 Dunn MS, Kaempf J, de Klerk A,. de Klerk R, Reilly M, Howard D, Ferrelli K, Orell OJ, Soll RF. Vermont Oxford Network DRM Study Group: Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics. 2011;128:1069–1076.

.5 Bancalari EH, Jobe AH. The respiratory course of extremely preterm infants: a dilemma for diagnosis and terminology. J. Pediatr. 2012;161:585–588.

.6 Stoll BJ, Hansen NI, Bell EF et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126:443–456.

.7 Sweet DG, Carnielli V, Greisen G et al. European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants – 2010 update. Neonatology. 2010;97:402–417.

.8 Rautava L, Eskelinen J, Häkkinen U et al. PERFECT Preterm Infant Study Group: 5-year morbidity among very preterm infants in relation to level of hospital care. Arch. Pediatr. Adolesc. Med. 2013;167:40–46.

.9 Baraldi E, Filippone M. Chronic lung disease after premature birth. N. Engl. J. Med. 2007;357:1946–1955.

.10 Stenmark KR, Abman SH. Lung vascular development: Implications for the pathogenesis of bronchopulmonary dysplasia. Ann Rev Physiol. 2005;67:623–661.

.11 Laughon M, Bose C, Allred EN. Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 2011;96(2).114-120.

.12 Bancalari EH, Jobe AH. The respiratory course of extremely preterm infants: a dilemma for diagnosis and terminology. J. Pediatr. 2012;161(4):585-588. DOI: 10.1016/j. jpeds.2012.05.054.

.13 Saugstad OD. Oxygen and oxidative stress in bronchopulmonary dysplasia. J.Perinat. Med. 2010;38:571–577.

.14 Gien J, Tseng N, Seedorf G et al. Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep. Pediatr. Res. 2013;73:252–262.

.15 Hayes JrD, Meadows Jr JT, Murphy BS et al. Pulmonary function outcomes in bronchopulmonary dysplasia through childhood and into adulthood: implications for primary care. Prim. Care. Respir. J.2011;20(2):128-33. Available from: http://dx.doi.or g/10.4104/pcrj.2011.00002.

.16 Levesque BM et al. Low urine vascular endothelial growth factor levels are associated with mechanical ventilation,bronchopulmonary dysplasia and retinopathy of prematurity / Neonatology. 2013;104:56–64.

.17 Ali Z, Schmidt P, Dodd J et al. Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children. Dan. Med. J. 2013;60:P.A4688.

.18 Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst. Rev. 2012; CD000510.

.19 Porto AM, Coutinho IC, Correia JB et al. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ. 2011;342:d1696.

.20 Gyamfi-Bannerman C, Gilbert S, Landon MB et al.Eunice Kennedy Shriver National Institute of Child Health, Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU): Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm birth. Obstet. Gynecol. 2012;119:555–559.

.21 Dawson JA, Kamlin CO, Wong C et al. Oxygen saturation and heart rate during delivery room resuscitation of infants. Pediatrics. 2010;127:255–259.

.22 Madurga A, Mizikova I, Ruiz-Camp JE. Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia. Am. J. Physiol. Lung. Cell. Mol. Physiol. 2013;893–905.

.23 Volodin NN, Bajbarina EN. Protokol vedenija nedonoshennyh detej s gemodinamicheski znachimym funkcionirujushhim arterial'nym protokom [Protocol for the management of premature infants with a hemodynamically significant functioning arterial duct]. Moskva; 2012.34p.(in Russian).

.24 Krjuchko DS, Bajbarina EN, Antonov AG, Rudakova AA. Otkrytyj arterial'nyj protok u nedonoshennyh novorozhdennyh [Open arterial duct in preterm infants]. Voprosy prakticheskoj pediatrii. 2010;5(2):57–65 (in Russian).

.25 Madan JC et al. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics. 2010;123(2):674-681.

.26 Adrouche-Amrani L, Green RS, Gluck KM et al. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infant. BMC Pediatrics. 2012;12:10. DOI: 10.1 186/1471-2431-12-10.

.27 Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst. Rev. 2013;4. CD003481.

.28 Clyman RI. The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia. Semin. Perinatol. 2013;37(2):102-7. DOI:10.1053/j.semperi.2013.01.006.

.29 Sosenko IR, Fajardo MF, Claure N et al. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. J. Pediatr. 2012;160:929.


Пристатейна бібліографія ГОСТ


1. Trembath A. Predictors of Bronchopulmonary Dysplasia / A. Trembath, M. Laughon // Clin Perinatol. – 2013. – Vol. 39(3). – P . 585–601.

2. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants / M.M. Laughon, J.C. Langer, C.L. Bose [et al.] // Am J Respir Crit Care Med. – 2011. – Vol. 183. – P. 1715–22.

3. Mourani P.M. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond / P.M. Mourani, S.H. Abman // Curr. Opin. Pediatr. – 2013. – Vol.25. – P.329–337.

4. Vermont Oxford Network DRM Study Group: Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates / M.S. Dunn, J. Kaempf, A. de Klerk, R. de Klerk, M. Reilly, D. Howard, K. Ferrelli, J. O Orell, R.F . Soll //Pediatrics. - 201 1. - Vol.128. - P.1069 –1076.

5. Bancalari EH. The respiratory course of extremely preterm infants: a dilemma for diagnosis and terminology / EH. Bancalari, AH. Jobe // J. Pediatr . – 2012. – Vol.161. – P.585–588.

6. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network / B. J. Stoll, N. I. Hansen, E. F . Bell [et al.] // Pediatrics. – 2010. – Vol. 126. – P. 443–456.

7. European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants – 2010 update / D.G. Sweet, V. Carnielli, G. Greisen [et al.] // Neonatology . – 2010. – Vol. 97. – P. 402–417.

8. PERFECT Preterm Infant Study Group: 5-year morbidity among very preterm infants in relation to level of hospital care / L. Rautava, J. Eskelinen, U. Häkkinen [et al.] // Arch. Pediatr. Adolesc. Med. – 2013. – Vol. 167. – P. 40–46.

9. Baraldi E. Chronic lung disease after premature birth / E. Baraldi, M. Filippone // N. Engl. J. Med. – 2007. – Vol. 357. – P . 1946–1955.

10. Stenmark K. R. Lung vascular development: Implications for the pathogenesis of bronchopulmonary dysplasia / K. R. Stenmark, S. H. Abman // Ann Rev Physiol. – 2005. – Vol. 67. – P . 623–661.

11. Laughon M. Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants / M.Laughon, C. Bose, E.N. Allred // Arch. Dis. Child. Fetal Neonatal Ed. – 201 1. – Vol.96(2). – P.114-120.

12. Bancalari E.H.The respiratory course of extremely preterm infants: a dilemma for diagnosis and terminology / E.H. Bancalari, A.H. Jobe // J. Pediatr. – 2012. – Vol.161(4). – P.585-588. doi: 10.1016/j. jpeds.2012.05.054. Epub 2012 Jul 10.

13. Saugstad O.D. Oxygen and oxidative stress in bronchopulmonary dysplasia / O.D. Saugstad // J.Perinat. Med. – 2010. – Vol. 38. – P . 571–577.

14. Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep / J. Gien, N. Tseng, G. Seedorf [et al.] // Pediatr . Res. – 2013. – Vol. 73. – P.252–262.

15. Pulmonary function outcomes in bronchopulmonary dysplasia through childhood and into adulthood: implications for primary care / Jr. D. Hayes, Jr. J.T. Meadows, B.S. Murphy [et al.] // Prim. Care. Respir. J. – 2011. – Vol. 20(2). – P. 128-33. – http://dx.doi.or g/10.4104/pcrj.2011.00002.

16. Low urine vascular endothelial growth factor levels are associated with mechanical ventilation,bronchopulmonary dysplasia and retinopathy of prematurity / B. M. Levesque [et al.] // Neonatology. – 2013. – Vol. 104. – P. 56–64.

17. Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children / Z. Ali, P. Schmidt, J. Dodd [et al.] // Dan. Med. J. – 2013. – Vol. 60. – P.A4688.

18. Rojas-Reyes M.X., Morley C.J., Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants / M.X. Rojas-Reyes, C.J. Morley, R. Soll // Cochrane Database Syst. Rev. – 2012. – CD000510.

19. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial / A.M. Porto, I.C. Coutinho, J.B. Correia [et al.] // BMJ. – 2011. – Vol. 342. – P. d1696.

20. Eunice Kennedy Shriver National Institute of Child Health, Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU): Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm birth / C. Gyamfi-Bannerman, S. Gilbert, M.B. Landon [et al.] // Obstet. Gynecol. – 2012. – Vol. 119. – P. 555–559.

21. Oxygen saturation and heart rate during delivery room resuscitation of infants / J.A. Dawson, C.O. Kamlin, C. Wong [et al.] // Pediatrics. – 2010. – Vol. 127. – P. 255–259.

22. Madurga A. Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia / A. Madurga, I. Mizikova, J.E. Ruiz-Camp // Am. J. Physiol. Lung. Cell. Mol. Physiol. – 2013. – P .893–905.

23. Володин Н.Н. Протокол ведения недоношенных детей с гемодинамически значимым функционирующим артериальным протоком / Н.Н. Володин, Е.Н. Байбарина.- М. – 2012. – C. 34.

24. Крючко Д.С. Открытый артериальный проток у недоношенных новорожденных / Д.С. Крючко, Е.Н. Байбарина, А.Г. Антонов, А.А. Рудакова // Вопросы практической педиатрии. – 2010. - т. 5, №2. – С. 57–65.

25. Madan J.C. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome / J.C. Madan [et al.] // Pediatrics. – 2010. – Vol.123(2). – P.674-681.

26. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infant / L. Adrouche-Amrani, R.S. Green, K.M. Gluck [et al.] // BMC Pediatrics. – 2012. – Vol. 12. – P.10. – doi: 10.1 186/1471-2431-12-10.

27. Ohlsson A. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants / A. Ohlsson, R. Walia, S.S. Shah // Cochrane Database Syst. Rev . – 2013. – Vol.4. – CD003481.

28. Clyman R.I. The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia / R.I. Clyman // Semin. Perinatol. – 2013. – Vol. 37(2). – P. 102-7. – doi:10.1053/j.semperi.2013.01.006.

29. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial / I.R. Sosenko, M.F. Fajardo, N. Claure [et al.] // J. Pediatr. – 2012. – Vol.160. – P. 929.



Посилання

  • Поки немає зовнішніх посилань.


Copyright (c) 2017 A. Obolonskyy, V. Snysar, O. Obolonskaya

Creative Commons License
Ця робота ліцензована Creative Commons Attribution 4.0 International License.

Creative Commons License
Журнал «Неонатологія, хірургія та перинатальна медицина» ISSN 2413-4260 (Online), ISSN 2226-1230 (Print) This work is licensed under a Creative Commons Attribution 4.0 International License.